How can arterial plaques be identified?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Identify Arterial Plaques

The most practical and evidence-based approach to identify arterial plaques combines carotid ultrasound for accessible peripheral vessels and coronary artery calcium (CAC) scoring for coronary assessment, with the ankle-brachial index (ABI) serving as a simple screening tool for systemic atherosclerosis. 1

Non-Invasive Detection Methods

Carotid Ultrasound - First-Line Peripheral Assessment

Carotid ultrasound is the most accessible method for detecting atherosclerotic plaques in asymptomatic individuals 1. This technique identifies:

  • Intima-media thickness (IMT): Values >0.9 mm indicate abnormal thickening and increased cardiovascular risk
  • Plaque presence: Defined as focal structures ≥0.5 mm (or >50% of surrounding IMT) or any IMT ≥1.5 mm
  • Plaque characteristics: Echolucent (unstable) plaques carry higher stroke risk than calcified plaques

Key advantage: Carotid ultrasound is non-invasive, widely available, and demonstrates that atherosclerosis in one arterial territory correlates with disease in other vessels, making it valuable for overall risk assessment 1.

Coronary Artery Calcium Scoring - Coronary Plaque Detection

CAC scoring via CT scan quantifies calcified plaque burden in coronary arteries 1:

  • Agatston score of 0: Nearly 100% negative predictive value for ruling out significant coronary narrowing
  • Positive calcium score: Confirms coronary atherosclerosis (though not necessarily significant stenosis)
  • Extent correlates with total plaque burden: Higher scores indicate more extensive disease

Important caveat: Coronary calcification indicates neither plaque stability nor instability. Non-calcified plaques can exist without calcium, so absence of calcium doesn't completely exclude disease 1.

Ankle-Brachial Index - Simple Screening Tool

The ABI is an easy, reproducible bedside test 1:

  • ABI <0.9: Indicates ≥50% stenosis between aorta and distal leg arteries with 79% sensitivity
  • Identifies systemic disease: 50-89% of patients with ABI <0.9 lack typical claudication symptoms
  • Predicts cardiovascular risk: Low ABI identifies higher-risk patients even in elderly populations

Advanced Imaging Modalities

Multislice CT Angiography (CCTA)

CCTA provides detailed coronary vessel visualization 2, 3:

  • Highest value: Negative predictive value approaching 98%
  • Can detect: Both calcified and non-calcified plaques
  • Limitation: Should not be used uncritically for screening; best reserved for high-risk subsets

Emerging Technologies (Limited Clinical Use)

  • MRI: Can differentiate plaque components in research settings but not yet appropriate for routine clinical identification of high-risk patients 2
  • Intravascular ultrasound (IVUS) and optical coherence tomography (OCT): Invasive techniques that provide detailed plaque characterization but require catheterization 4

Practical Clinical Algorithm

For asymptomatic individuals over 55 years:

  1. Start with ABI measurement - If <0.9, proceed with further evaluation
  2. Perform carotid ultrasound - Assess IMT and plaque presence/characteristics
  3. Consider CAC scoring - Particularly in intermediate-risk patients where results would change management
  4. Reserve CCTA - For specific high-risk populations where negative predictive value is most useful

Critical pitfall: Calcium scanning is widely applied but should not be used uncritically as a screening method without considering the clinical context and patient risk profile 2.

Gender Considerations

Women require special attention 2:

  • CVD risk is deferred by 10 years compared to men (a 55-year-old woman equals a 45-year-old man in risk)
  • Carotid IMT appears more predictive in women than men
  • Diabetes carries considerably greater fatal CVD risk in women

The combination of these non-invasive methods provides comprehensive assessment of systemic atherosclerotic burden without requiring invasive procedures, allowing for appropriate risk stratification and treatment decisions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.